How biobanks can help improve the integrity of scientific research

Biobanks are repositories which receive, store, process and disseminate specimens. These include DNA derived from humans and animals; bacterial strains; and environmental samples like plants and soil. Biobanks also provide the vital infrastructure for research to support scientific advancement and innovation.

In the developed world, biobanks are well established and generally well funded and supported. There are also biobanks in the developing world like regions in Africa, most notably in South Africa and Nigeria – but the technology is really still in its infancy. Simple issues like internet connectivity, access to reliable water and electricity supply, which are all necessary to run biobanks, are common.

Yet it’s in the developing world that biobanks could be especially powerful tools. For example, having access to the rich genetic diversity across Africa would allow researchers to understand disease, develop better diagnostics and treatments, medicines and vaccines, geared toward the continent’s population.

Crucially, they can also improve scientists’ ability to replicate results and experiments, a process known as reproducibility. This is very important because being able to reproduce research verifies results and means it can be trusted. Biobanks have high quality assurance and control measures in place, making them safe, reliable spaces to store material for repeated testing that could lead to trustworthy science that saves lives.

This is why low and middle income countries, like those in Africa, should prioritise setting up biobanks despite the high cost and other challenges.

A reproducibility crisis

A recent study has shown that, across the world, scientists’ ability to reproduce research is staggeringly low. More than 70% of the 1 500 scientific participants in the study could not replicate other scientists’ experiments. And half were unable to replicate their own experiments.

This costs a huge amount of money. In the US alone, the estimated financial burden of not being able to replicate research translates to approximately $28-billion per year that’s being spent on life science research which cannot be replicated.

Why don’t researchers rigorously investigate the reproducibility of experimental works before releasing the findings? There are a few reasons.

Firstly, research costs money; costs for any lab are already high and staff may not want to spend more than they believe is necessary.

Secondly, reproducing experiments takes time – and when scientists are developing novel therapies for diseases, for instance, time can cost lives.

The study also identified study design, biological samples, laboratory protocols, and data analysis and reporting as issues. So it stands to reason that implementing standard best practices and adhering to them could partially ease the crisis.

That’s where biobanks come in.

Quality assurance

Most biobanks, whether small or large, have high quality assurance and control measures in place. Without this, they won’t generate the trust needed to function well. They ensure that sample transportation, processing, storage and analysis are done according to standard methods. They manage risk to ensure the biospecimens they store for different researchers or teams are viable and retain their quality.

Biobanks which follow best practice guidelines can be mediators for reproducible scientific research as they ensure that protocols are applied in a standardised, harmonised way.

This means that researchers who use a biobank can have some level of comfort that, at a bare minimum, any biological sample used in an experiment is consistent and controlled. For example, biobanks that use Laboratory Information Management System software can track and log a sample’s life cycle to ensure its quality hasn’t been compromised. For example, Baobab LIMS was developed at the University of the Western Cape as a management system for human biobanks.

Sample quality is critical in research, as it will influence later analysis. Biobanks are also an important tool for smaller laboratories that don’t have the finances to get international accreditation, or don’t have the right equipment for analysing specific samples.

Benefits outweigh costs

It may seem like a no-brainer to establish biobanks everywhere, given all the benefits they offer.

But there are some barriers to this happening in the developing world. Cost is one. Biobanks are generally non-profit. Non-commercial medical biobanks cannot sell specimens, as this would equate to trade in human tissue and is unethical. So biobanks’ fee structure is aimed entirely at cost-recovery.

There’s also a lack of highly skilled and trained personnel. There are some international certificates and courses specifically for biobanking, offered in North America and Europe but for the most part, skilled scientists could be trained to become proficient and staff biobanks.

These issues should be dealt with by policy makers, governments and science stakeholders. The benefits of establishing more biobanks clearly outweigh the costs – especially in the face of the ever increasing direct and indirect cost of research that cannot be reproduced and the growing need to preserve Africa’s rich genomic resources.

Dominique Anderson, Postdoctoral researcher in Metagenomics, University of the Western Cape; Alan Christoffels, DST/NRF Research Chair in Bioinformatics and Public Health Genomics, University of the Western Cape, and Carmen Swanepoel, Principal Medical Scientist within the Division of Haematopathology, Stellenbosch University

This article was originally published on The Conversation. Read the original article.

The Conversation

Subscribe to the M&G for R2 a month

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.

And for this weekend only, you can become a subscriber by paying just R2 a month for your first three months.

Related stories

Covid vaccines: Hope balanced with caution

As Covid vaccines near the manufacturing stage, a look at two polio vaccines provides valuable historical insights

Extract from ‘The Journey’: Responses to the archive

This sequence of texts was written in response to various photographs of Nigeria made between 1920 and 1929 that form part of the Colonial Office photographic collection

The world’s warriors are under attack, but we must keep on fighting

The murder of Fikile Ntshangase in KwaZulu-Natal was not an isolated incident. Around the globe, from Nigeria to Brazil, environmental activists are similarly being silenced, and it is our duty to continue this struggle

Nigeria’s queers say ‘enough’

Notorious police unit that harassed LGBTQ+ community disbanded after widespread protests.

Meet Donald Trump’s Nigerian cheerleaders

If Nigerians got to choose the next US president, Donald Trump would be the clear favourite

Why anti-corruption campaigns are bad for democracy

Such campaigns can draw attention to the widespread presence of the very behaviour they are trying to stamp out — and subconsciously encourage people to view it as appropriate

Subscribers only

ANC: ‘We’re operating under conditions of anarchy’

In its latest policy documents, the ANC is self-critical and wants ‘consequence management’, yet it’s letting its members off the hook again

Q&A Sessions: ‘I think I was born way before my...

The chief executive of the Estate Agency Affairs Board and the deputy chair of the SABC board, shares her take on retrenchments at the public broadcaster and reveals why she hates horror movies

More top stories

Between dark and light was Maradona

The life of Diego Armando Maradona, who died this week, will always remind us that the smell of shit is as important as the perfume of flowers, writes Niren Tolsi

Public protector’s ‘mistakes’ were made to nail the president, court...

Busisiwe Mkhwebane discarded facts that were inconvenient to her when she investigated the CR17 campaign, Cyril Ramaphosa’s lawyers argued

Student funding scheme gets new chief executive and board

The National Student Financial Aid Scheme has been under administration for two years after its board was dissolved and its boss resigned not even halfway through his term

General Council of the Bar slams Zuma Foundation

Another summons has been served on Jacob Zuma at his Nkandla residence, requiring the former president to appear before the Zondo Commission next year

press releases

Loading latest Press Releases…